A Phase 1, Open Label, Single Sequence, Two-Way Drug Interaction Study Evaluating Plasma GSK2248761 and GSK1379572 Pharmacokinetics in Healthy Adult Subjects

Trial Profile

A Phase 1, Open Label, Single Sequence, Two-Way Drug Interaction Study Evaluating Plasma GSK2248761 and GSK1379572 Pharmacokinetics in Healthy Adult Subjects

Withdrawn prior to enrolment
Phase of Trial: Phase I

Latest Information Update: 05 Jan 2015

At a glance

  • Drugs Dolutegravir (Primary) ; Fosdevirine (Primary)
  • Indications HIV-1 infections
  • Focus Pharmacokinetics
  • Sponsors GlaxoSmithKline; ViiV Healthcare
  • Most Recent Events

    • 26 Oct 2014 Status changed from suspended to withdrawn prior to enrolment, as per ClinicalTrials.gov record.
    • 11 Mar 2011 Actual initiation date (Mar 2011) added as reported by ClinicalTrials.gov.
    • 11 Mar 2011 Status changed from not yet recruiting to suspended as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top